Perimeter Medical Imaging AI to Unveil Innovations at Life Sciences Virtual Investor Forum on June 12

Perimeter Medical Imaging to Present at the Investor Forum

Perimeter Medical Imaging AI, Inc. has announced their upcoming participation in the Life Sciences Virtual Investor Forum, scheduled for June 12, 2025. This forum will be an exciting opportunity for investors and stakeholders to gain insight into the company’s innovative advancements in medical imaging technology. The presentation will commence at 12:30 p.m. Eastern Time and serve as a platform for the company’s CEO, Adrian Mendes, to offer a detailed update about the current status and future prospects of Perimeter.

As a leader in the field of cancer surgery technology, Perimeter Medical is committed to addressing significant unmet medical needs through their cutting-edge imaging tools. The company is based in Toronto, Canada, and Dallas, Texas, and it operates under the ticker symbols PINK on TSXV and PYNKF on OTCQX. Their FDA-approved Perimeter S-Series OCT system is designed to provide real-time, high-resolution imagery of excised tissues, delivering vital information at the cellular level to surgeons during operations. This innovation aims to enhance outcomes for cancer patients by improving surgical precision.

Additionally, the presentation will highlight the company’s next-generation artificial intelligence system, the Perimeter B-Series OCT with ImgAssist AI. This investigational technology, which recently underwent a pivotal clinical trial, was made possible with significant financial support from grants awarded by the Cancer Prevention and Research Institute of Texas, showcasing Perimeter's commitment to leading advancements in cancer care.

During the forum, attendees will have access to a live stream of the presentation on the company’s website, where it will also be archived for a later viewing period of approximately 90 days. This initiative reflects Perimeter’s dedication to transparency and engagement with investors and the public interest as they continue to develop groundbreaking medical technologies.

In addition to exploring Perimeter's latest technologies and developments in cancer surgery, Adrian Mendes is expected to address future strategic goals, anticipated events, and upcoming market trends. With a focus on continual improvement and innovative research, Perimeter aims to solidify its position as a game-changer in the medical technology field.

Perimeter Medical Imaging AI emphasizes the importance of informed investment decisions and the potential impact of their advancements on future cancer treatment methodologies. With the complexities involving regulatory approvals and clinical testing, Mendes will provide commentary on navigating these challenges while maintaining the company’s trajectory towards success.

To stay informed about Perimeter’s developments and participate in their continued narrative, stakeholders are encouraged to attend the presentation on June 12 and visit their website for the archived version thereafter. This event not only stands as a crucial moment for Perimeter but also a significant opportunity for various investors to connect with a pioneering entity in healthcare technology.

For more updates, visit Perimeter's website which features various disclosures, investor information, and insights into their operational efforts toward revolutionizing cancer care.

With the stakes higher than ever in the healthcare industry, this forum could mark a pivotal moment for both Perimeter Medical and its stakeholders, as they align the goal of improving patient outcomes with the continued growth and robustness of cancer treatments today.